Literature DB >> 19035938

Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis.

Y L Woo1, J Sterling, I Damay, N Coleman, R Crawford, S H van der Burg, M Stanley.   

Abstract

INTRODUCTION: Immunological competence influences the progression of cervical intraepithelial neoplasia (CIN) to invasive cancer. Information on the local immunological changes during the natural course of CIN is central for the development of new therapies.
OBJECTIVE: This study defines the populations of tissue-infiltrating immune cells in a cross-sectional cohort of different grades of CIN and also in a longitudinal cohort of regressing, persistent and progressing low-grade (LG)-CIN.
DESIGN: A cohort of 125 women with LG cytological atypia was recruited, of which 64/125 (51%) women with LG-CIN were followed prospectively for 1 year. Paraffin-embedded entry and exit cervical biopsies were used for immunohistochemistry analysis (CD4, CD8, CD56, FOXP3, CD1a and granzyme B).
RESULTS: At recruitment, 74/125 (59%), 39/125 (31%) and 12/125 (10%) women referred with LG smears had histologically proven LG-CIN, high-grade (HG) and normal biopsies, respectively. Seventeen of 64 (24.6%) women with LG-CIN progressed to HG-CIN within 1 year. In both LG-CIN and HG-CIN, the predominant intraepithelial cell population were cytotoxic T cells, while CD4+ and FOXP3+ T cells predominated the stromal compartment. Women with LG-CIN who later on regressed displayed a significantly higher number of cytotoxic (granzyme B+) cells in their entry samples. In addition, the ratio between CD8+ cells and granzyme B+ cells was close to 1, suggesting that all infiltrating CD8+ T cells were highly active. In contrast, this ratio was three-fold lower in women, in whom the lesions persisted or progressed.
CONCLUSIONS: This study suggests that the early infiltration of lesions by highly cytotoxic effector cells protects against progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035938     DOI: 10.1111/j.1471-0528.2008.01936.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  26 in total

1.  Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy.

Authors:  Matthew P Morrow; Kimberly A Kraynyak; Cornelia L Trimble; Mark L Bagarazzi; Albert J Sylvester; Michael Dallas; Dawson Knoblock; Jean D Boyer; Jian Yan; Russell Vang; Amir S Khan; Laurent Humeau; Niranjan Y Sardesai; J Joseph Kim; Stanley Plotkin; David B Weiner
Journal:  Clin Cancer Res       Date:  2017-10-30       Impact factor: 12.531

Review 2.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

3.  Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.

Authors:  Astrid M Bedoya; Roberto Jaramillo; Armando Baena; Jorge Castaño; Natalia Olaya; Arnold H Zea; Rolando Herrero; Gloria I Sanchez
Journal:  Cancer Microenviron       Date:  2012-01-31

4.  Immunosuppressive tumor microenvironment in cervical cancer patients.

Authors:  Sytse J Piersma
Journal:  Cancer Microenviron       Date:  2011-05-31

5.  Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.

Authors:  Loane Decrausaz; Sonia Domingos-Pereira; Mélanie Duc; Martine Bobst; Pedro Romero; John T Schiller; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

6.  Stress Management, Depression and Immune Status in Lower Income Racial/Ethnic Minority Women Co-infected with HIV and HPV.

Authors:  Corina R Lopez; Michael H Antoni; Deirdre Pereira; Julia Seay; Nicole Whitehead; Jonelle Potter; Maryjo O'Sullivan; Mary Ann Fletcher
Journal:  J Appl Biobehav Res       Date:  2013-03-08

7.  Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia.

Authors:  Cléber Sergioda da Silva; Marcia Antoniazi Michelin; Renata Margarida Etchebehere; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

8.  Leukocyte infiltration as a surrogate marker for diagnosis of invasion.

Authors:  Aijun Liu; Lixin Wei
Journal:  Int J Biol Sci       Date:  2010-04-28       Impact factor: 6.580

Review 9.  Tumour virus vaccines: hepatitis B virus and human papillomavirus.

Authors:  Margaret Stanley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

Review 10.  HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and Treatment.

Authors:  Cornelia L Trimble
Journal:  Cancer Immunol Res       Date:  2014-10       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.